These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4041336)

  • 1. The effect of ranitidine on the disposition of lignocaine.
    Robson RA; Wing LM; Miners JO; Lillywhite KJ; Birkett DJ
    Br J Clin Pharmacol; 1985 Aug; 20(2):170-3. PubMed ID: 4041336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of effect of ranitidine on the disposition of lignocaine.
    Feely J; Guy E
    Br J Clin Pharmacol; 1983 Mar; 15(3):378-9. PubMed ID: 6133546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lidocaine disposition--sex differences and effects of cimetidine.
    Wing LM; Miners JO; Birkett DJ; Foenander T; Lillywhite K; Wanwimolruk S
    Clin Pharmacol Ther; 1984 May; 35(5):695-701. PubMed ID: 6713782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of histamine-2 receptor blockade on lidocaine kinetics.
    Jackson JE; Bentley JB; Glass SJ; Fukui T; Gandolfi AJ; Plachetka JR
    Clin Pharmacol Ther; 1985 May; 37(5):544-8. PubMed ID: 3987178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the influence of antacids and H2 antagonists on the absorption of moxifloxacin after oral administration of a 400mg dose to healthy volunteers.
    Stass H; Böttcher MF; Ochmann K
    Clin Pharmacokinet; 2001; 40 Suppl 1():39-48. PubMed ID: 11352441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of ranitidine on the disposition of orally and intravenously administered triazolam.
    Vanderveen RP; Jirak JL; Peters GR; Cox SR; Bombardt PA
    Clin Pharm; 1991 Jul; 10(7):539-43. PubMed ID: 1860302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of ranitidine on the disposition of metoprolol.
    Kelly JG; Salem SA; Kinney CD; Shanks RG; McDevitt DG
    Br J Clin Pharmacol; 1985 Feb; 19(2):219-24. PubMed ID: 3986080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose and concentration dependent effect of ranitidine on procainamide disposition and renal clearance in man.
    Somogyi A; Bochner F
    Br J Clin Pharmacol; 1984 Aug; 18(2):175-81. PubMed ID: 6091709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of equimolar doses of cimetidine and ranitidine on theophylline elimination.
    Adebayo GI
    Biopharm Drug Dispos; 1989; 10(1):77-85. PubMed ID: 2923963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ranitidine does not alter pethidine disposition in man.
    Guay DR; Meatherall RC; Chalmers JL; Grahame GR; Hudson RJ
    Br J Clin Pharmacol; 1985 Jul; 20(1):55-9. PubMed ID: 4027136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of efficacy of cimetidine and ranitidine as inhibitors of tolbutamide metabolism.
    Adebayo GI; Coker HA
    Eur J Clin Pharmacol; 1988; 34(6):653-6. PubMed ID: 3169118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased toxicity and reduced clearance of lidocaine by cimetidine.
    Feely J; Wilkinson GR; McAllister CB; Wood AJ
    Ann Intern Med; 1982 May; 96(5):592-4. PubMed ID: 7073151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of ranitidine on chloroquine disposition.
    Ette EI; Brown-Awala A; Essien EE
    Drug Intell Clin Pharm; 1987 Sep; 21(9):732-4. PubMed ID: 2888638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of the H2- receptor antagonist ranitidine in man.
    McNeil JJ; Mihaly GW; Anderson A; Marshall AW; Smallwood RA; Louis WJ
    Br J Clin Pharmacol; 1981 Sep; 12(3):411-5. PubMed ID: 6117305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of interaction of cimetidine and ranitidine with intravenous and oral midazolam.
    Greenblatt DJ; Locniskar A; Scavone JM; Blyden GT; Ochs HR; Harmatz JS; Shader RI
    Anesth Analg; 1986 Feb; 65(2):176-80. PubMed ID: 2935051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of oral bioavailability of lignocaine by induction of first pass metabolism in epileptic patients.
    Perucca E; Richens A
    Br J Clin Pharmacol; 1979 Jul; 8(1):21-31. PubMed ID: 552293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impairment of lignocaine clearance by propranolol--major contribution from enzyme inhibition.
    Bax ND; Tucker GT; Lennard MS; Woods HF
    Br J Clin Pharmacol; 1985 May; 19(5):597-603. PubMed ID: 2860914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of ranitidine in patients with renal failure.
    Garg DC; Baltodano N; Jallad NS; Perez G; Oster JR; Eshelman FN; Weidler DJ
    J Clin Pharmacol; 1986 Apr; 26(4):286-91. PubMed ID: 3700684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of 'therapeutic' doses of beta-adrenoceptor antagonists to alter the disposition of tolbutamide and lignocaine.
    Miners JO; Wing LM; Lillywhite KJ; Smith KJ
    Br J Clin Pharmacol; 1984 Dec; 18(6):853-60. PubMed ID: 6152176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ranitidine and cimetidine; drug interactions with single dose and steady-state nifedipine administration.
    Smith SR; Kendall MJ; Lobo J; Beerahee A; Jack DB; Wilkins MR
    Br J Clin Pharmacol; 1987 Mar; 23(3):311-5. PubMed ID: 3567045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.